Shrier Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Shrier Wealth Management's BMY Position: Q3 2026 in Review
Shrier Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.18% in Q3 2026, buying an estimated $442 and bringing the position to 4,003 shares worth $250K. The position accounts for 0.08% of the portfolio, ranked #120.
Shrier Wealth Management first reported a position in BMY in Q4 2025 and has held it in 4 quarters since. 2,561 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Shrier Wealth Management held 4,003 shares of Bristol-Myers Squibb worth $250K as of Q3 2026.
- Shrier Wealth Management bought 7 Bristol-Myers Squibb shares in Q3 2026, an estimated $442.
- Bristol-Myers Squibb made up 0.08% of Shrier Wealth Management's portfolio in Q3 2026, its #120 holding.
- Shrier Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 4 quarters since.
- 2,561 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.